Edition 05

The targeted therapy Venetoclax (Venclexta) can now be used for a broader group of patients with chronic lymphocytic leukemia (CLL). The U.S. Food and Drug…


Read More

Edition 04

The US Food and Drug Administration (FDA) has approved Pembrolizumab (Keytruda) for patients with recurrent or metastatic cervical cancer with disease…


Read More

Edition 03

The US Food and Drug Administration (FDA) has approved simultaneous administration of Tafinlar (Dabrafenib) and Mekinist (Trametinib) for treatment of…


Read More

Edition 02

FDA approved Osimertinib (Tagrisso) for the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) whose tumors have epidermal…


Read More

Edition 01

PDL-1 expression has already shown us favorable prognosis in treatment of many solid cancers. As per latest advancements, PDL-1 amplification, although rare in…


Read More